Consun Pharmaceutical Group Limited (01681.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.6x

Market Cap

HKD 11.54B

MomentumView details →

1D Return

−0.44%

YTD Return

−12.98%

RSI (14)

48.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.6x

Market Cap

HKD 11.54B

RSI (14)

48.7

MomentumView details →

1D Return

−0.44%

YTD Return

−12.98%

ProfitabilityView details →

Gross Margin

78.44%

Net Margin

31.64%

EBITDA Margin

36.02%

ROE (TTM)

45.71%

ROA (TTM)

31.86%

Asset Turnover

1.04x

GrowthView details →

Revenue YoY

+32.11%

EPS YoY

+30.61%

FCF YoY

−31.16%

Revenue CAGR 3Y

+13.46%

EPS CAGR 3Y

+13.58%

EBITDA YoY

+37.39%

EarningsView details →

EPS (Actual)

HKD 0.81

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

1.28%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

2.91x

Quick Ratio

2.76x

Div Yield

5.36%

Div Rate

HKD 0.40

Div Growth 1Y

−36.51%

Financials snapshotView financials →

Revenue (TTM)

6.88B

Net Income (TTM)

2.18B

Op. CF (TTM)

—

Next earningsMar 24, 2027 →

Latest newsMore news →

China Shineway Pharmaceutical Group Limited announced its interim results for the six months ended June 30, 2026, reporting revenue of RMB 1.785 billion, up 13.8% year-on-year, and profit attributable to shareholders of RMB 595 million, up 19.5% year-on-year.10d ago

Similar companies

Ab&B Bio Tech Co Ltd.02627.HK 微芯生物688321.SH 国药现代600420.SH 羚锐制药600285.SH 国邦医药605507.SH Sunshine Lake Pharma Co., Ltd.06887.HK Find similar companies →

Latest newsMore news →

China Shineway Pharmaceutical Group Limited announced its interim results for the six months ended June 30, 2026, reporting revenue of RMB 1.785 billion, up 13.8% year-on-year, and profit attributable to shareholders of RMB 595 million, up 19.5% year-on-year.10d ago